World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
68207
World Ranking
3690
National Ranking
102

Overview

Olivier Sitbon is affiliated with the University of Paris-Saclay in France. Their research primarily focuses on Medicine, with a significant concentration in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Surgery, Hepatology, and Genetics.

The scientist's work extensively covers topics including:

  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Issues in Pregnancy
  • Cardiovascular Function and Risk Factors
  • Liver Disease and Transplantation
  • Heart Failure Treatment and Management
  • Vascular Anomalies and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Olivier Sitbon has published in several key scientific venues such as:

  • European Respiratory Journal
  • Revue des Maladies Respiratoires Actualités
  • American Journal of Respiratory and Critical Care Medicine
  • The Journal of Heart and Lung Transplantation
  • ERJ Open Research

Recent publications include:

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Respiratory Journal
  • ERS statement on chronic thromboembolic pulmonary hypertension, 2020, European Respiratory Journal
  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study, 2022, The Lancet Respiratory Medicine

Frequent co-authors collaborating with Olivier Sitbon are:

  • Marc Humbert
  • David Montani
  • Laurent Savale
  • Xavier Jaïs
  • Athénaïs Boucly

The body of work by Olivier Sitbon demonstrates involvement across multiple interconnected fields of study with a focus on diseases and treatments related to pulmonary hypertension and cardiovascular conditions. Their contributions span diagnostic guidelines, clinical trials, and disease-specific research published in specialized respiratory and cardiovascular journals.

Best Publications

  • Pulmonary arterial hypertension in France: results from a national registry.

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • Inhaled iloprost for severe pulmonary hypertension.

    Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam

  • Treatment of Pulmonary Arterial Hypertension

    Marc Humbert;Olivier Sitbon;Gérald Simonneau

  • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

    Richard N Channick;Gérald Simonneau;Olivier Sitbon;Ivan M Robbins

  • Long-Term Intravenous Epoprostenol Infusion in Primary Pulmonary Hypertension Prognostic Factors and Survival

    Olivier Sitbon;Marc Humbert;Hilario Nunes;Florence Parent

  • Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • Macitentan and morbidity and mortality in pulmonary arterial hypertension.

    Tomás Pulido;Igor Adzerikho;Richard N. Channick;Marion Delcroix

  • Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

    Olivier Sitbon;Marc Humbert;Xavier Jaïs;Vincent Ioos

  • Diagnosis and differential assessment of pulmonary arterial hypertension

    Robyn J Barst;Michael McGoon;Adam Torbicki;Olivier Sitbon

  • Selexipag for the treatment of pulmonary arterial hypertension.

    Olivier Sitbon;Richard Channick;Kelly M Chin;Aline Frey

  • Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

    M Humbert;G Monti;F Brenot;O Sitbon

  • Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial

    Ge rald Simonneau;Lewis J. Rubin;Nazzareno Galie;Robyn J. Barst

  • Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

    Nazzareno Galie;Marc Humbert;Jean-Luc Vachiery;Carmine Dario Vizza

  • Survival with first-line bosentan in patients with primary pulmonary hypertension

    Vv Mclaughlin;O Sitbon;Db Badesch;Rj Barst

  • Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

    M. Humbert;O. Sitbon;A. Yaïci;D. Montani

  • Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

    David Montani;Emmanuel Bergot;Sven Günther;Laurent Savale

  • Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

    Robyn J. Barst;J. Simon R. Gibbs;Hossein A. Ghofrani;Marius M. Hoeper

  • Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

    Athénaïs Boucly;Athénaïs Boucly;Jason Weatherald;Jason Weatherald;Laurent Savale;Laurent Savale;Xavier Jaïs;Xavier Jaïs

  • Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

    Olivier Sitbon;Caroline Lascoux-Combe;Jean-François Delfraissy;Patrick G. Yeni

  • Pulmonary arterial hypertension

    David Montani;Sven Günther;Peter Dorfmüller;Frédéric Perros

Frequent Co-Authors

Marc Humbert
Marc Humbert University of Paris-Saclay
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
David Montani
David Montani University of Paris-Saclay
Xavier Jaïs
Xavier Jaïs University of Paris-Saclay
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Florent Soubrier
Florent Soubrier Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare doesn’t always mean becoming an MD. For students considering alternative pathways or aiming to advance their nursing education, there are flexible online options to fit different career goals.

Many nurses are now seeking rn bsn online programs no clinicals, allowing them to earn a bachelor’s degree without the need for additional clinical hours. This makes it easier for working professionals to balance job and studies.

Those aspiring for leadership or advanced clinical roles often choose doctorate programs. Accelerated options, like a 1 year dnp program online, allow experienced nurses to complete their Doctor of Nursing Practice in a shorter time-frame. Others prefer the convenience of easiest dnp programs, which offer flexible coursework and minimal on-campus requirements.

Entry into nursing can also be streamlined. Applicants with limited time or resources may consider enrolling in an lpn fast track program to start their healthcare careers quickly.

Overall, online degrees and accelerated pathways make it simpler for students at every stage—from entry-level to advanced practice—to progress in the healthcare field.

Best Scientists Citing Olivier Sitbon

Trending Scientists

Recently Published Articles